U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C51H72N5O10P
Molecular Weight 946.1186
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of VINFOSILTINE

SMILES

[H][C@@]12N3CC[C@@]14C5=C(C=C(OC)C(=C5)[C@]6(C[C@@]7([H])CN(C[C@](O)(CC)C7)CCC8=C6NC9=C8C=CC=C9)C(=O)OC)N(C)[C@@]4([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(=O)N[C@H](C(C)C)P(=O)(OCC)OCC

InChI

InChIKey=BOELCLFVOBIXIF-MAKKXPIGSA-N
InChI=1S/C51H72N5O10P/c1-10-47(60)27-32-28-50(46(59)64-9,40-34(19-23-55(29-32)30-47)33-17-14-15-18-37(33)52-40)36-25-35-38(26-39(36)63-8)54(7)43-49(35)21-24-56-22-16-20-48(11-2,42(49)56)44(57)51(43,61)45(58)53-41(31(5)6)67(62,65-12-3)66-13-4/h14-18,20,25-26,31-32,41-44,52,57,60-61H,10-13,19,21-24,27-30H2,1-9H3,(H,53,58)/t32-,41-,42-,43+,44+,47-,48+,49+,50-,51-/m0/s1

HIDE SMILES / InChI

Molecular Formula C51H72N5O10P
Molecular Weight 946.1186
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 10
E/Z Centers 0
Optical Activity UNSPECIFIED

Vinfosiltine (also known as S 12363) was developed as a vinca alkaloid derivative. It is known that vinca alkaloids are widely used in the medical treatment of breast cancer. Vinfosiltine participated in the phase II clinical trial to treat the patients with advanced breast cancer. The results have shown that the drug didn’t have significant single-agent activity. As a result, the development of vinfosiltine was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Evaluation of the time-schedule dependency for the cytotoxic activity of the new vinca alkaloid derivative, S 12363 (vinfosiltine).
1993
Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer.
1995

Sample Use Guides

a randomization was performed between two schedules with the same dose intensity, that is, 0.3 mg/m2 given weekly or 0.6 mg/m2 given every 2 weeks
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:47:11 GMT 2023
Edited
by admin
on Fri Dec 15 17:47:11 GMT 2023
Record UNII
AW1UYE6Q9I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
VINFOSILTINE
INN  
INN  
Official Name English
vinfosiltine [INN]
Common Name English
(23(S))-4-DEACETYL-3-DE(METHOXYCARBONYL)-3-((2-METHYL-1-PHOSPHONOPROPYL)CARBAMOYL)VINCALEUKOBLASTINE, DIETHYL ESTER
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C932
Created by admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
NCI_THESAURUS C67422
Created by admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL2103757
Created by admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
PRIMARY
EPA CompTox
DTXSID10153930
Created by admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
PRIMARY
PUBCHEM
70691387
Created by admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
PRIMARY
SMS_ID
100000079092
Created by admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
PRIMARY
FDA UNII
AW1UYE6Q9I
Created by admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
PRIMARY
EVMPD
SUB00065MIG
Created by admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
PRIMARY
NCI_THESAURUS
C2378
Created by admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
PRIMARY
INN
6735
Created by admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
PRIMARY
CAS
123286-00-0
Created by admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY